A Phase III Study Evaluating the Efficacy and Safety of Remimazolam (CNS 7056) Compared to Placebo and Midazolam in Patients Undergoing Bronchoscopy
Phase of Trial: Phase III
Latest Information Update: 03 Aug 2017
At a glance
- Drugs Remimazolam (Primary) ; Midazolam
- Indications Sedation
- Focus Registrational; Therapeutic Use
- Sponsors PAION
- 28 Jul 2017 Status changed from recruiting to completed.
- 28 Jun 2017 Primary endpoint of success of procedure has been met, according to a PAION media release.
- 28 Jun 2017 Results published in a PAION Media Release